Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Cancer|December 1, 1987
Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trialG N Hortobagyi, A U Buzdar, D Frye, et al.
Breast Cancer Research and Treatment|January 1, 1985
Oral medroxyprogesterone acetate in the treatment of metastatic breast cancerG N Hortobagyi, A U Buzdar, D Frye, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experienceN K Ibrahim, G N Hortobagyi, M Ewer, et al.
Cancer|January 1, 1989
Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinomaG N Hortobagyi, D Frye, A U Buzdar, et al.
American Journal of Clinical Oncology|January 1, 1990
Pirarubicin in combination chemotherapy for metastatic breast cancerG N Hortobagyi, R L Theriault, D Frye, et al.
Cancer|February 1, 1990
Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?A U Buzdar, M D McNeese, G N Hortobagyi, et al.
Cancer|May 1, 1982
Peptichemio versus melphalan (L-PAM) in advanced breast cancerA U Buzdar, S S Legha, G R Blumenschein, et al.
Cancer|January 9, 2001
Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapyE Rivera, F A Holmes, D Frye, et al.
Cancer|November 15, 1988
Adjuvant therapy of breast cancer with or without additional treatment with alternate drugsA U Buzdar, G N Hortobagyi, T L Smith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experienceE H Koh, A U Buzdar, F C Ames, et al.
Pageof 6